Monitoring reports of the effectiveness of COVID-19 vaccination
Data on the real-world efficacy of the COVID-19 vaccines.
Ann mark this message contains misinformation
｜originally written by Ann
部分錯誤。影片中的講者為克羅埃西亞歐洲議會議員Mislav Kolakušić，其對於英國疫苗數據的解讀，含有錯誤資訊，但指稱輝瑞因沒有提出防止人際傳播的疫苗數據，應該返還預算等內容，則為個人意見。
1. 英國國家統計局（ONS）數據及衛生安全局（UKHSA）對疫苗有效性的監測，已顯示接種COVID-19疫苗能降低重症與死亡率。
根據英國確診死亡與接種狀態的分析，各年齡層中，接種三劑疫苗的死亡率確實低於未接種或接種兩劑以下者。研究也指出，輝瑞加強劑對於重症、住院能提供97％至99％的保護力。影片提及英國相關數據「完全不因接種疫苗有所差別」，為錯誤資訊。
2. 輝瑞國際市場總裁Janine Small確實表示，疫苗上市前未研究其是否能阻止病毒傳播，但疫苗臨床測試的用意，本來就只在於確認預防疾病與重症的功效，而非「阻止傳播」。Kolakušić認為歐盟應終止合約、輝瑞應返還預算等內容，僅為個人意見。
（1）埃默里大學疫苗中心副主任Walter Orenstein博士表示，「傳播」是複雜的衡量指標，輝瑞在臨床試驗期間沒有研究疫苗對傳播的影響並非特例。
（2）輝瑞自始沒有聲稱病毒能阻止傳播。美國FDA於2020年12月11日通過疫苗授權的新聞稿，也明白表示「目前，沒有數據可以確定疫苗將提供多長時間的保護，也沒有證據表明該疫苗可防止SARS-CoV-2在人與人之間傳播。」
（3） 費城兒童醫院疫苗教育中心主任Paul Offit指出：「當你接種疫苗，將明顯降低你被感染的機率，因此也會降低你將其傳播給他人的機會」，雖不能保證消除所有的傳播，但疫苗上市後的研究確實發現，輝瑞疫苗有助於減少alpha和delta變種的傳播。
1. 英國國家統計局（ONS）數據及衛生安全局（UKHSA）對疫苗有效性的監測，已顯示接種COVID-19疫苗能降低重症與死亡率。
根據英國確診死亡與接種狀態的分析，各年齡層中，接種三劑疫苗的死亡率確實低於未接種或接種兩劑以下者。研究也指出，輝瑞加強劑對於重症、住院能提供97％至99％的保護力。影片提及英國相關數據「完全不因接種疫苗有所差別」，為錯誤資訊。
2. 輝瑞國際市場總裁Janine Small確實表示，疫苗上市前未研究其是否能阻止病毒傳播，但疫苗臨床測試的用意，本來就只在於確認預防疾病與重症的功效，而非「阻止傳播」。Kolakušić認為歐盟應終止合約、輝瑞應返還預算等內容，僅為個人意見。
（1）埃默里大學疫苗中心副主任Walter Orenstein博士表示，「傳播」是複雜的衡量指標，輝瑞在臨床試驗期間沒有研究疫苗對傳播的影響並非特例。
（2）輝瑞自始沒有聲稱病毒能阻止傳播。美國FDA於2020年12月11日通過疫苗授權的新聞稿，也明白表示「目前，沒有數據可以確定疫苗將提供多長時間的保護，也沒有證據表明該疫苗可防止SARS-CoV-2在人與人之間傳播。」
（3） 費城兒童醫院疫苗教育中心主任Paul Offit指出：「當你接種疫苗，將明顯降低你被感染的機率，因此也會降低你將其傳播給他人的機會」，雖不能保證消除所有的傳播，但疫苗上市後的研究確實發現，輝瑞疫苗有助於減少alpha和delta變種的傳播。
References
英國衛生安全局（UKHSA）：Monitoring reports of the effectiveness of COVID-19 vaccinationhttps://www.gov.uk/guidance/monitoring-reports-of-the-effectiveness-of-covid-19-vaccination
英國國家統計局（ONS）：Deaths involving COVID-19 by vaccination status, England: deaths occurring between 1 January 2021 and 31 May 2022
https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/bulletins/deathsinvolvingcovid19byvaccinationstatusengland/deathsoccurringbetween1january2021and31may2022
Effectiveness of COVID-19 booster vaccines against COVID-19-related symptoms, hospitalization and death in England
https://www.nature.com/articles/s41591-022-01699-1
Posts mislead on Pfizer COVID vaccine’s impact on transmission
https://apnews.com/article/fact-check-pfizer-transmission-european-parliament-950413863226
politifact: Pfizer executive “admits” vaccine was never tested for preventing transmission.
https://www.politifact.com/factchecks/2022/oct/13/instagram-posts/alleged-revelation-about-pfizer-vaccine-trial-noth/
Effect of Covid-19 Vaccination on Transmission of Alpha and Delta Variants
https://www.nejm.org/doi/full/10.1056/nejmoa2116597#:~:text=Conclusions,only partially explained decreased transmission.
FDA Takes Key Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for First COVID-19 Vaccine
https://www.fda.gov/news-events/press-announcements/fda-takes-key-action-fight-against-covid-19-issuing-emergency-use-authorization-first-covid-19
https://www.gov.uk/guidance/monitoring-reports-of-the-effectiveness-of-covid-19-vaccination
Deaths involving COVID-19 by vaccination status, England - Office for National Statistics
Age-standardised mortality rates for deaths involving COVID-19 by vaccination status, broken down by age group. Deaths occurring between 1 January 2021 and 31 May 2022 in England.
Effectiveness of COVID-19 booster vaccines against COVID-19-related symptoms, hospitalization and death in England
Nature Medicine - A test-negative case–control analysis of data from the National Immunisation Management System in England demonstrates significant levels of increased protection against...
Cannot get data from URL
PolitiFact - Alleged revelation about Pfizer vaccine trial is nothing new
A video of an exchange between a Dutch politician and a Pfizer executive is being framed by some as a shocking revelation about the COVID-19 vaccine trials. It’s not. Since 2020, Pfizer has said trial
https://www.nejm.org/doi/full/10.1056/nejmoa2116597#:~:text=Conclusions,only
FDA Takes Key Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for First COVID-19 Vaccine
Today, the FDA issued the first EUA for a vaccine for the prevention of COVID-19 caused by SARS-CoV-2 in individuals 16 years of age and older.
The content above by Cofacts message reporting chatbot and crowd-sourced fact-checking community is licensed under Creative Commons Attribution-ShareAlike 4.0 (CC BY-SA 4.0), the community name and the provenance link for each item shall be fully cited for further reproduction or redistribution.